Serogenetics, Cytogenetics and Ethics in Reproductive Technology — 2026 Paper I
In what manner is our understanding of serogenetics and cytogenetics useful in reproductive biology? What are the major ethical issues involved in reproductive technology?
Model Answer
VAID ICSApproach
|
Model Answer
Introduction: Serogenetics studies inherited variation in blood-group and serum markers, while cytogenetics examines chromosome number, Answer structure and Flow and behaviour. Both have made major contributions to reproductive biology, although contemporary molecular genetics now supplements many classical applications.
Serogenetics in reproductive biology:
- ABO, Rh and other red-cell antigen systems helped establish Mendelian inheritance and historically assisted parentage exclusion.
- The most important reproductive application is maternal–fetal blood-group incompatibility. An RhD-negative mother carrying an RhD-positive fetus may become sensitised and produce IgG anti-D antibodies. These can cross the placenta in a subsequent susceptible pregnancy and cause haemolytic disease of the fetus/newborn.
- Serological screening and anti-D immunoprophylaxis therefore have direct preventive importance.
- Blood-group and serum-protein polymorphisms also contributed historically to population/reproductive genetics and genetic counselling.
Cytogenetics in reproductive biology:
- Karyotyping and related chromosome-based tests detect aneuploidies and structural rearrangements relevant to infertility, recurrent pregnancy loss and prenatal diagnosis.
- Examples include trisomy 21, Turner syndrome, Klinefelter syndrome and balanced translocations in clinically normal parents that may generate unbalanced gametes.
- Cytogenetic findings inform genetic counselling and, where clinically justified, may guide reproductive decision-making and embryo testing.
Major ethical issues in reproductive technology:
- informed consent and counselling under uncertainty;
- privacy and future use of reproductive/genetic data;
- moral status, storage, research use and disposal of embryos;
- embryo selection, disability concerns and possible eugenic tendencies;
- non-medical sex/trait selection;
- donor anonymity, parentage and the future child’s interest in genetic origins;
- commercialisation of gametes and possible exploitation in surrogacy;
- unequal access to expensive technologies;
- heritable genome editing, off-target risk and absence of consent from future generations.
Conclusion: Serogenetics made reproductive inheritance and blood-group compatibility visible, while cytogenetics made chromosome-level reproductive risk diagnosable. As reproductive intervention becomes more powerful, biological capability must be balanced by autonomy, justice, non-exploitation and intergenerational responsibility.
Want feedback on your answer?
Join the Anthropology workshop or get structured answer-writing guidance from VAID ICS.